Azetidine glycine transporter inhibitors

Details for Australian Patent Application No. 2005243192 (hide)

Owner Merck Sharp & Dohme Limited Merck & Co., Inc.

Inventors Hallett, David; Wolkenberg, Scott E.; Lindsley, Craig W.

Agent Spruson & Ferguson

Pub. Number AU-A-2005243192

PCT Pub. Number WO2005/110983

Priority 60/566,334 29.04.04 US

Filing date 25 April 2005

Wipo publication date 24 November 2005

International Classifications

C07D 205/04 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/110983 Priority application(s): WO2005/110983

18 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005243193-Antibodies specific for glycoprotein VI and methods of producing these anti- bodies

2005243188-Beta-carbolines useful for treating inflammatory disease